Pacific Biosciences of California Inc (PACB) is up Thursday morning, with the stock adding 2.15% in pre-market trading to 9.5.
PACB's short-term technical score of 57 indicates that the stock has traded more bullishly over the last month than 57% of stocks on the market. In the Medical Devices industry, which ranks 122 out of 146 industries, the stock ranks higher than 70% of stocks.
Pacific Biosciences of California Inc has risen 10.45% over the past month, closing at $10.02 on November 10. During this period of time, the stock fell as low as $9.10 and as high as $12.37. PACB has an average analyst recommendation of Buy. The company has an average price target of $12.33.
PACB has an Overall Score of 55. Find out what this means to you and get the rest of the rankings on PACB!
Pacific Biosciences of California Inc has a Long-Term Technical rank of 76. This means that trading over the last 200 trading days has placed the company in the upper half of stocks with 24% of the market scoring higher. In the Medical Devices industry which is number 118 by this metric, PACB ranks better than 118% of stocks.
